Assuming progression is required, the following results were found.

  • Genentech Presents New Six-Year Ocrevus (Ocrelizumab) Data Which Showed That Earlier Initiation and Continuation of Treatment Reduced Disability Progression in Multiple Sclerosis

    patients who were treated with Ocrevus® (ocrelizumab) continuously for six years or more had reduced risk of disability progression in relapsing MS (RMS) and primary progressive MS (PPMS). These results suggest earlier treatment with Ocrevus reduced the...

    https://mschristian.org/index.php/blog/genentech-presents-new-six-year-ocrevus-ocrelizumab-data-which-showed-that-earlier-initiation-and-continuation-of-treatment-reduced-disability-progression-in-multiple-sclerosis
  • Disability progression in multiple sclerosis linked to income, education

    Neighbourhood income and education level is associated with risk of disability progression in patients with multiple sclerosis, suggests new research from the University of British Columbia. UBC researchers, along with colleagues in Wales, compared...

    https://mschristian.org/index.php/blog/disability-progression-in-multiple-sclerosis-linked-to-income-education
  • Researchers Identify Nerve Cells That Are Vulnerable to Damage in MS

    July 18, 2019 Findings contribute to efforts to stopping MS progression SUMMARYCollaborators in Cambridge and San Francisco used advanced technology to evaluate genetic instructions within single brain cells in specific areas of brain tissues from...

    https://mschristian.org/index.php/blog/researchers-identify-nerve-cells-that-are-vulnerable-to-damage-in-ms
  • How the gut influences neurologic disease

    Researchers are identifying the key players involved in the gut-brain connection and their role in disease progression Date:Source:Brigham and Women's HospitalSummary:A study sheds new light on the connection between the gut and the brain, untangling...

    https://mschristian.org/index.php/blog/how-the-gut-influences-neurologic-disease
  • Four-Year Study Confirms That Imaging the Eye with OCT Provides Window to MS Progression in the Brain and a Way to Track the Effects of Therapies

    inexpensive and well tolerated imaging method. These findings suggest that OCT findings reflect underlying disease progression, and further validate the usefulness of OCT as an important tool for tracking MS and the impacts in clinical trials. The...

    https://mschristian.org/index.php/blog/four-year-study-confirms-that-imaging-the-eye-with-oct-provides-window-to-ms-progression-in-the-brain-and-a-way-to-track-the-effects-of-therapies
  • Genentech to Present Pivotal Data for Satralizumab in Neuromyelitis Optica Spectrum Disorder and Six-year Ocrevus (Ocrelizumab) Data in Multiple Sclerosis at ECTRIMS

    into neurofilament light chain (NfL) levels as a potential biomarker for predicting multiple sclerosis (MS) disability progression; new longer-term Ocrevus data of more than six years show reduction of disability progression in relapsing and primary...

    https://mschristian.org/index.php/blog/genentech-to-present-pivotal-data-for-satralizumab-in-neuromyelitis-optica-spectrum-disorder-and-six-year-ocrevus-ocrelizumab-data-in-multiple-sclerosis-at-ectrims
  • What to know about secondary progressive multiple sclerosis (SPMS)

    SPMS. According to the National Multiple Sclerosis Society, most people with RRMS will eventually develop a secondary progression course that involves a gradual worsening of symptoms over time. Table of contents Secondary progressive multiple sclerosis...

    https://mschristian.org/index.php/blog/what-to-know-about-secondary-progressive-multiple-sclerosis-spms-1
  • A molecular key for delaying the progression of Multiple Sclerosis is found

    harmful when it is prolonged over time, leading to chronic inflammation, and aggravates the disease and encourages its progression. In the work just published it was possible to identify a receptor known as P2X4 present in the microglial cells that...

    https://mschristian.org/index.php/blog/a-molecular-key-for-delaying-the-progression-of-multiple-sclerosis-is-found
  • MS: High-strength MRI may predict disease progression

    for people with multiple sclerosis (MS). The scientists used a high-strength MRI to detect lesions and evaluate the progression of the disease. They published their findings in the journal Radiology. To track the MS participants for the study, the...

    https://mschristian.org/index.php/blog/ms-high-strength-mri-may-predict-disease-progression-1
  • SPMS and Diet: What Foods Can Help?

    Many treatments for multiple sclerosis (MS) are targeted at reducing inflammation, thereby slowing progression of the autoimmune disease. An anti-inflammatory diet also may slow disease progression, as well as enhance the positive effects of...

    https://mschristian.org/index.php/blog/spms-and-diet-what-foods-can-help
  • Siponimod Delays Time to Wheelchair in Secondary Progressive MS - Neurology Times

    of Lille, at ECTRIMS 2019, September 11-13 in Stockholm, Sweden. “Siponimod has been shown to reduce disability progression, not only physically based on Expanded Disability Status Scale [EDSS], but also reduced cognitive decline in a typical secondary...

    https://mschristian.org/index.php/blog/siponimod-delays-time-to-wheelchair-in-secondary-progressive-ms-neurology-times
  • Multiple sclerosis treatments delay progression of the disease

    and University of Melbourne-led study is the first to provide evidence that the currently available therapies can delay progression of disability in Multiple Sclerosis. It showed that early treatment -- particularly within five years of onset -- delayed...

    https://mschristian.org/index.php/blog/multiple-sclerosis-treatments-delay-progression-of-the-disease
  • New research to stop Multiple Sclerosis - WILX-TV

    MI. (WILX) - Dr. Rany Aburashed at Memorial Healthcare in Owosso is conducting new research to potentially stop the progression of Multiple Sclerosis. A woman who witnessed the struggles of Multiple Sclerosis (MS) in a family member is now battling the...

    https://mschristian.org/index.php/blog/new-research-to-stop-multiple-sclerosis-wilx-tv
  • Research Project 3TR To Use Breath Biopsy, Improve Immune-mediated Disease Management - Technology Networks

    globe and pose a substantial burden to healthcare systems. While different treatments are available, response and disease progression in individual patients remain unpredictable, which can hamper the management of their disease. In a never-before-seen...

    https://mschristian.org/index.php/blog/research-project-3tr-to-use-breath-biopsy-improve-immune-mediated-disease-management-technology-networks
  • #ECTRIMS2019 - Are Injectables Inappropriate for Active Relapsing MS? - Multiple Sclerosis News Today

    with first-line injectables, offer benefits in several clinical outcomes, namely annual relapse rates, disability progression, treatment resistance, and health-related quality of life. With more high-efficacy therapies becoming available, is it now...

    https://mschristian.org/index.php/blog/ectrims2019-are-injectables-inappropriate-for-active-relapsing-ms-multiple-sclerosis-news-today
  • #ECTRIMS2019 - Mayzent's Benefits for MS Patients a 'Key Question,' Says EXPAND's Principal Investigator - Multiple Sclerosis News Today

    active and non-active), the study showed that taking 2 mg tablets of Mayzent once per day reduced the risk of disability progression at three months by 33% in those with active, relapsing disease, and by 13% in those with non-active SPMS. The therapy...

    https://mschristian.org/index.php/blog/ectrims2019-mayzent-s-benefits-for-ms-patients-a-key-question-says-expand-s-principal-investigator-multiple-sclerosis-news-today
  • #ECTRIMS2019 - Transplanting MSCs Safe, Helps Stop Progressive MS - Multiple Sclerosis News Today

    Transplanting mesenchymal stem cells (MSCs) is safe and can delay disease progression in people with active, progressive multiple sclerosis (MS), according to results from a single-center clinical trial conducted in Israel. Six months after the...

    https://mschristian.org/index.php/blog/ectrims2019-transplanting-mscs-safe-helps-stop-progressive-ms-multiple-sclerosis-news-today
  • Sex chromosome contributions to sex differences in multiple sclerosis susceptibility and progression

    AH2, Itoh Y1. AbstractBACKGROUND: Why are women more susceptible to multiple sclerosis, but men have worse disability progression? Sex differences in disease may be due to sex hormones, sex chromosomes, or both. OBJECTIVE: Determine whether differences...

    https://mschristian.org/index.php/blog/sex-chromosome-contributions-to-sex-differences-in-multiple-sclerosis-susceptibility-and-progression
  • MS Progression Stopped by Targeting T Helper Cells with CXCR6 Receptor in Mouse Model - Multiple Sclerosis News Today

    that antibodies targeting T helper cells — known drivers of MS — that carry the CXCR6 receptor may slow or prevent MS progression without broadly dampening the immune system. The study “SerpinB1 controls encephalitogenic T helper cells in...

    https://mschristian.org/index.php/blog/ms-progression-stopped-by-targeting-t-helper-cells-with-cxcr6-receptor-in-mouse-model-multiple-sclerosis-news-today
  • How new gene discoveries could guide precision medicine in multiple sclerosis

    that our study opens up a new line of investigation targeting complement genes as a potential way to treat disease progression and nerve cell death,” said Peter Calabresi, M.D., professor of neurology and neuroscience and co-director of the Johns...

    https://mschristian.org/index.php/blog/how-new-gene-discoveries-could-guide-precision-medicine-in-multiple-sclerosis

Results 1 - 20 of 65
 
 

Follow Us on Twitter

Follow Us On Twitter - Image